Skip to main content

Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal.

Publication ,  Journal Article
Erdoes, G; Koster, A; Levy, JH
Published in: Anesthesiology
February 1, 2024

Duke Scholars

Published In

Anesthesiology

DOI

EISSN

1528-1175

Publication Date

February 1, 2024

Volume

140

Issue

2

Start / End Page

189 / 191

Location

United States

Related Subject Headings

  • Sulfonamides
  • Pipecolic Acids
  • Humans
  • Critical Illness
  • Anticoagulants
  • Anesthesiology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Erdoes, G., Koster, A., & Levy, J. H. (2024). Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal. Anesthesiology, 140(2), 189–191. https://doi.org/10.1097/ALN.0000000000004814
Erdoes, Gabor, Andreas Koster, and Jerrold H. Levy. “Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal.Anesthesiology 140, no. 2 (February 1, 2024): 189–91. https://doi.org/10.1097/ALN.0000000000004814.
Erdoes G, Koster A, Levy JH. Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal. Anesthesiology. 2024 Feb 1;140(2):189–91.
Erdoes, Gabor, et al. “Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal.Anesthesiology, vol. 140, no. 2, Feb. 2024, pp. 189–91. Pubmed, doi:10.1097/ALN.0000000000004814.
Erdoes G, Koster A, Levy JH. Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal. Anesthesiology. 2024 Feb 1;140(2):189–191.

Published In

Anesthesiology

DOI

EISSN

1528-1175

Publication Date

February 1, 2024

Volume

140

Issue

2

Start / End Page

189 / 191

Location

United States

Related Subject Headings

  • Sulfonamides
  • Pipecolic Acids
  • Humans
  • Critical Illness
  • Anticoagulants
  • Anesthesiology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences